Choose a company to view its profile and explore their unique contributions.
The 2026 European Neurofibromatosis Conference is a collaborative milestone led by NF Kinder and the Medical University of Vienna. Endorsed by the European Neurofibromatosis Group, Children's Tumor Foundation, and ERN GENTURIS, these partners are united in advancing global research and patient care. This alliance drives essential innovation and international cooperation.
The 2026 European Neurofibromatosis Conference in Vienna (12–14 November) is now fully booked. Explore advances in NF1, Schwannomatosis, and patient-centred research at Hyatt Regency Vienna (previously Andaz Vienna Am Belvedere).